Intravitreal Dexamethasone in the Management of Delayed-Onset Bleb-Associated Endophthalmitis

Table 1

Baseline demographics, clinical presentation, and initial culture results.

	IVD	No IVD	𝑃 value
	70/83 (84%)	13/83 (16%)
Age
Mean, SD	74 yr (12)	70 yr (14)	0.27
Gender
Female	34 (49%)	8 (62%)	0.39
Male	36 (51%)	5 (39%)
Diabetes mellitus
Present	9 (13%)	2 (15%)	0.81
Absent	61 (87%)	11 (85%)
Antimetabolites (MMC or 5FU)
Used	45 (64%)	7 (54%)	0.47
Not used	25 (36%)	6 (46%)
Mean time of onset, SD	60 mo (43)	49 mo (55)	0.46
Bleb leak
Present	16 (23%)	5 (38%)	0.23
Absent	54 (77%)	8 (62%)
Anterior chamber
Hypopyon	48 (69%)	10 (77%)	0.55
View to fundus
Hazy	22 (31%)	8 (62%)	0.04
Poor/none	48 (69%)	5 (39%)
Intraocular Pressure
Presentation, SD	20 (14)	19 (12)	0.8
Treatment, initial
Tap and injection	41 (59%)	12 (92%)	0.03
Pars plana vitrectomy	29 (41%)	1 (8%)
Treatment, additional
Filtering procedure	12 (17%)	1 (8%)	0.39
Pars plana vitrectomy	21 (30%)	2 (15%)	0.28
Culture results
Culture positive	46 (66%)	6 (46%)	0.18
Culture negative	24 (34%)	7 (54%)
Gram-positive cases	33 (47%)	4 (31%)	0.28
Streptococcus	19 (27%)	2 (15%)	0.37
Coagulase-negative Staphylococcus	7 (10%)	2 (15%)	0.57
Enterococcus	6 (9%)	0	0.27
Staphylococcus aureus	1 (1%)	0	0.67
Gram-negative cases	12 (17%)	2 (15%)	0.88
Moraxella	8 (11%)	0	0.2
Pseudomonas	2 (3%)	1 (8%)	0.39
Serratia	1 (1%)	1 (8%)	0.18